Loopbaan van Christian Kjellman
Eerdere bekende functies van Christian Kjellman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| HANSA BIOPHARMA AB | Operationeel Directeur | 01-01-2008 | 01-02-2023 |
| Hoofd Techniek/Wetenschap/O&O | 01-01-2008 | 01-02-2023 | |
| BIOINVENT INTERNATIONAL AB | Corporate Officer/Principal | - | - |
| University of Lund | Corporate Officer/Principal | - | - |
Cartela AB
 Cartela AB Pharmaceuticals: MajorHealth Technology Cartela AB develops therapies for arthritic diseases. It products are mainly used by osteoarthritis and rheumatoid arthritis. Its business is based on the cell surface molecules, integrants a10ß1 and a11ß1. The company was founded by Evy Lundgren-Åkerlund and Donald Gullberg in 2000 and is headquartered in Lund, Sweden. | Hoofd Techniek/Wetenschap/O&O | - | - |
Opleiding van Christian Kjellman
| University of Lund | Graduate Degree |
Statistieken
Internationaal
| Zweden | 5 |
Operationeel
| Chief Tech/Sci/R&D Officer | 2 |
| Corporate Officer/Principal | 2 |
| Graduate Degree | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| HANSA BIOPHARMA AB | Health Technology |
| BIOINVENT INTERNATIONAL AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Cartela AB
Cartela AB Pharmaceuticals: MajorHealth Technology Cartela AB develops therapies for arthritic diseases. It products are mainly used by osteoarthritis and rheumatoid arthritis. Its business is based on the cell surface molecules, integrants a10ß1 and a11ß1. The company was founded by Evy Lundgren-Åkerlund and Donald Gullberg in 2000 and is headquartered in Lund, Sweden. | Health Technology |
- Beurs
- Insiders
- Christian Kjellman
- Ervaring
